Regeneron has signaled plans to initiate Phase 3 trials, likely in 2027, using its own in-licensed GLP-1/GIP dual agonist (olatorepatide) as the incretin backbone rather than Novo Nordisks semaglutide
doi: 10.1126/science.abb8034 22 GiardiniV.CarrerA.CasatiM.ControE.VerganiP.Gambacorti-PasseriniC
Product Overview: Tirzepatide is a novel once-weekly injectable peptide medication that acts as a dual GIP (glucose-dependent insulinotropic polypeptide) receptor agonist and GLP-1 (glucagon-like peptide-1) receptor agonist
Hair, Skin & Nails: The combination of vitamin C, lysine, and amino acids help support collagen production resulting in brighter and more youthful skin, stronger nails, and more vibrant hair
My philosophy as a functional medicine doctor in Houston involves treating the entire person as it relates to hormones, nutrition, lifestyle & aesthetics to help each patient fulfill their health and wellness goals by attaining and maintaining balance in their lives and restoring vitality
Yes an aggressive or sustained calorie deficit can directly trigger binge eating episodes by raising ghrelin (the hunger hormone) and lowering leptin (the satiety hormone), creating powerful biological urges to overeat
)
